SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 539 filers reported holding SEAGEN INC in Q3 2022. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,431,601 | +12.0% | 20,889 | +1.6% | 0.09% | +7.0% |
| Q2 2023 | $3,955,053 | -7.4% | 20,550 | -2.6% | 0.09% | -17.3% |
| Q1 2023 | $4,273,332 | +196.9% | 21,106 | +88.5% | 0.10% | +153.7% |
| Q4 2022 | $1,439,183 | +12.5% | 11,199 | +19.8% | 0.04% | +7.9% |
| Q3 2022 | $1,279,000 | -25.8% | 9,348 | -4.1% | 0.04% | -30.9% |
| Q2 2022 | $1,724,000 | +62.5% | 9,744 | +32.3% | 0.06% | +66.7% |
| Q1 2022 | $1,061,000 | +15.3% | 7,365 | +23.8% | 0.03% | +10.0% |
| Q4 2021 | $920,000 | +8.7% | 5,951 | +19.4% | 0.03% | -11.8% |
| Q3 2021 | $846,000 | +25.5% | 4,985 | +16.7% | 0.03% | +17.2% |
| Q2 2021 | $674,000 | -75.2% | 4,272 | -78.2% | 0.03% | -76.0% |
| Q1 2021 | $2,722,000 | +180.0% | 19,599 | +253.3% | 0.12% | +278.1% |
| Q4 2020 | $972,000 | – | 5,547 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 47,288,259 | $7,465,870,000 | 32.79% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 145,000 | $22,868,000 | 6.04% |
| Lagoda Investment Management, L.P. | 59,780 | $9,438,000 | 4.40% |
| Avidity Partners Management LP | 640,000 | $101,043,000 | 2.73% |
| PFM Health Sciences, LP | 482,985 | $76,254,000 | 2.39% |
| Boxer Capital, LLC | 400,000 | $63,152,000 | 2.23% |
| Redmile Group, LLC | 771,385 | $121,786,000 | 1.80% |
| Woodline Partners LP | 577,655 | $91,200,000 | 1.70% |
| Rhenman & Partners Asset Management AB | 157,925 | $24,933,000 | 1.69% |
| Parkman Healthcare Partners LLC | 45,176 | $7,132,000 | 1.56% |